Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease

Author： Alexander L. Pukhalsky   Galina V. Shmarina   Nikolai I. Kapranov   Svetlana N. Kokarovtseva   Daria Pukhalskaya   Natalia J. Kashirskaja  

Publisher： Informa Healthcare

ISSN： 1466-1861

Source： Mediators of Inflammation, Vol.13, Iss.2, 2004-04, pp. : 111-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection

By Pukhalsky A. L.   Kapranov N. I.   Kalashnikova E. A.   Shmarina G. V.   Shabalova L. A.   Kokarovtseva S. N.   Pukhalskaya D. A.   Kashirskaja N. J.   Simonova O. I.  

Mediators of Inflammation, Vol. 8, Iss. 3, 1999-06 ,pp. : 159-167

Informa Healthcare

Access to resources Recommend Favorite

Pathogenesis of Lung Disease in Cystic Fibrosis

By  

Respiration, Vol. 67, Iss. 1, 2000-02 ,pp. : 3-8

Karger

Access to resources Recommend Favorite

Steady-State Therapy with Azithromycin or Low-Dose Prednisolone in Paediatric Cystic Fibrosis Patients: Inflammatory Markers and Disease Progression

By  

International Archives of Allergy and Immunology, Vol. 172, Iss. 1, 2017-02 ,pp. : 45-54

Karger

Access to resources Recommend Favorite

Early Detection of Lung Disease and Its Association with the Nutritional Status, Genetic Background and Life Events in Patients with Cystic Fibrosis

By  

Respiration, Vol. 67, Iss. 5, 2000-10 ,pp. : 477-490

Karger

Access to resources Recommend Favorite

Association of chronic Candida albicans respiratory infection with a more severe lung disease in patients with cystic fibrosis

By  

PEDIATRIC PULMONOLOGY, Vol. 50, Iss. 11, 2015-11 ,pp. : 1082-1089

John Wiley & Sons Inc

Access to resources Recommend Favorite